Relevancia clínica de la interacción clopidogrel y omeprazol: revisión sistemática

Revista Colombiana de Cardiología - Tập 19 - Trang 25-32 - 2012
Héctor Holguín1, Mauricio Ceballos1, Pedro Amariles1
1Grupo de investigación, promoción y prevención farmacéutica, Universidad de Antioquia, Medellín, Colombia

Tài liệu tham khảo

Pramparo, 2006, Cardiovascular diseases in Latin America and the Caribbean: The present situation, Prevention and Control, 2, 149, 10.1016/j.precon.2007.03.002

Toth, 2009, Thienopyridine therapy and risk for cardiovascular events in secondary prevention, Curr Atheroscler Rep, 11, 364, 10.1007/s11883-009-0055-1

2002, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, 324, 71, 10.1136/bmj.324.7329.71

Mehta, 2010, Dose comparisons of clopidogrel and aspirin in acute coronary syndromes, N Engl J Med, 363, 930, 10.1056/NEJMoa0909475

Bhatt, 2006, Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events, N Engl J Med, 354, 1706, 10.1056/NEJMoa060989

Ogawa, 2010, Drug-drug interaction profiles of proton pump inhibitors, Clin Pharmacokinet, 49, 509, 10.2165/11531320-000000000-00000

Hollopeter, 2001, Identification of the platelet ADP receptor targeted by antithrombotic drugs, Nature, 409, 202, 10.1038/35051599

Savi, 2000, Identification and biological activity of the active metabolite of clopidogrel, Thromb Haemost, 84, 891, 10.1055/s-0037-1614133

Sanofi-Aventis. Plavix prescribing information. Disponible en: http://www.products.sanofi-aventis.us/PLAVIX/PLAVIX.html#PRECAUTIONS.

Ferreiro, 2010, Pharmacodynamic effects of concomitant versus staggered clopidogrel and omeprazole intake: results of a prospective randomized crossover study, Circ Cardiovasc Interv, 3, 436, 10.1161/CIRCINTERVENTIONS.110.957829

Nogueira, 2005, Raman spectroscopy study of atherosclerosis in human carotid artery, J Biomed Opt, 10, 031117, 10.1117/1.1908129

Muntner, 2011, Association of high-density lipoprotein cholesterol with coronary heart disease risk across categories of low-density lipoprotein cholesterol: The Atherosclerosis Risk in Communities Study, Am J Med Sci, 341, 173, 10.1097/MAJ.0b013e3181f97e4a

Masood, 2009, In-hospital outcome of acute myocardial infarction in correlation with thrombolysis in myocardial infarction’ risk score, J Ayub Med Coll Abbottabad, 21, 24

Baldominos G. Estudio de efectividad y seguridad de la enoxaparina para la profilaxis de la enfermedad tromboembólica venosa en pacientes hospitalizados por patología médica. Tesis de doctorado. Departamento de Medicina, Universidad de Alcalá; 1992.

García, 2000, Características estructurales y funcionales de las plaquetas, Rev Cubana Angiol y Cir Vasc, 1, 132

Zaidi, 1996, Adhesion of platelets to surface-bound fibrinogen under flow, Blood, 88, 2967, 10.1182/blood.V88.8.2967.bloodjournal8882967

Abraham, 2010, J Am Coll Cardiol, 56, 2051, 10.1016/j.jacc.2010.09.010

Tran, 2004, Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheralarterial disease, JAMA, 292, 1867, 10.1001/jama.292.15.1867

Patrono, 2005, Low-dose aspirin for the prevention of atherothrombosis, N Engl J Med, 353, 2373, 10.1056/NEJMra052717

1996, A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE), Lancet, 348, 1329, 10.1016/S0140-6736(96)09457-3

Lanas, 2007, Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants, Am J Gastroenterol, 102, 507, 10.1111/j.1572-0241.2006.01062.x

Savi, 1998, Clopidogrel: a review of its mechanism of action, Platelets, 9, 251, 10.1080/09537109876799

Product Information: PLAVIX(R) oral tablets, clopidogrel bisulfate oral tablets. Bristol- Myers Squibb/Sanofi Pharmaceuticals Partnership, Bridgewater, NJ., 2010.

Savi, 2000, Identification and biological activity of the active metabolite of clopidogrel, Thromb Haemost, 84, 891, 10.1055/s-0037-1614133

Kazui, 2010, Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite, Drug Metab Dispos, 38, 92, 10.1124/dmd.109.029132

Mega, 2009, Cytochrome P-450 polymorphisms and response to clopidogrel, N Engl J Med, 360, 354, 10.1056/NEJMoa0809171

Roden, 2009, Clopidogrel and the concept of high-risk pharmacokinetics, Circulation, 119, 2127, 10.1161/CIRCULATIONAHA.109.865907

Shuldiner, 2009, Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy, JAMA, 302, 849, 10.1001/jama.2009.1232

Bhatt, 2010, Clopidogrel with or without omeprazole in coronary artery disease, N Engl J Med, 363, 1909, 10.1056/NEJMoa1007964

Bhatt, 2008, ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents, J Am Coll Cardiol, 52, 1502, 10.1016/j.jacc.2008.08.002

Lai, 2002, Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use, N Engl J Med, 346, 2033, 10.1056/NEJMoa012877

Ng, 2008, Gastrointestinal bleeding in patients receiving a combination of aspirin, clopidogrel, and enoxaparin in acute coronary syndrome, Am J Gastroenterol, 103, 865, 10.1111/j.1572-0241.2007.01715.x

Shi, 2008, Proton pump inhibitors: an update of their clinical use and pharmacokinetics, Eur J Clin Pharmacol, 64, 935, 10.1007/s00228-008-0538-y

Drugs.com: Drug Information OnLine. Clopidogrel [artículo en internet]. Dsiponible en: http://www.drugs.com/pro/clopidogrel.html. [consulta: 03 de noviembre de 2010].

Blume, 2006, Pharmacokinetic drug interaction profiles of proton pump inhibitors, Drug Saf, 29, 769, 10.2165/00002018-200629090-00002

Amariles, 2007, Interacciones medicamentosas en pacientes infectados con el VIH: aproximación para establecer y evaluar su relevancia clínica, Farm Hosp, 3, 283, 10.1016/S1130-6343(07)75392-8

European Medicines Agency. Public statement on possible interaction between clopidogrel and proton-pump inhibitors [artículo en internet]. Disponible en: http://www.emea.europa.eu/humandocs/PDFs/EPAR/Plavix/32895609en.pdf [consulta: 03 de noviembre de 2010].

US Food and Drug Administration. Early communication about an ongoing safety review of clopidogrel bisulfate (marketed as Plavix) [artículo en internet]. Disponible en: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm079520.htm [consulta: 03 de noviembre de 2010].

Sibbing, 2009, Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel, Thromb Haemost, 101, 714, 10.1160/TH08-12-0808

Norgard, 2009, Drug-drug interaction between clopidogrel and the proton pump inhibitors, Ann Pharmacother, 43, 1266, 10.1345/aph.1M051

Juhász, 2010, Current standings of the proton pump inhibitor and clopidogrel co-therapy: review on an evolving field with the eyes of the gastroenterologist, Digestion, 81, 10, 10.1159/000243717

Oyetayo, 2010, Proton pump inhibitors and clopidogrel: is it a significant drug interaction?, Expert Opin Drug Saf, 9, 593, 10.1517/14740331003645609

Gilard, 2008, Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole Clopidogrel Aspirin) study, J Am Coll Cardiol, 51, 256, 10.1016/j.jacc.2007.06.064

Siriswangvat, 2010, Comparison between the effect of omeprazole and rabeprazole on the antiplatelet action of clopidogrel, Circ J, 74, 2187, 10.1253/circj.CJ-09-0913

Yun, 2010, Effects of omeprazole on the antiplatelet activity of clopidogrel, Int Heart J, 51, 13, 10.1536/ihj.51.13

Juurlink, 2009, A population-based study of the drug interaction between proton pump inhibitors and clopidogrel, CMAJ, 180, 713, 10.1503/cmaj.082001

Zairis, 2010, The impact of treatment with omeprazole on the effectiveness of clopidogrel drug therapy during the first year after successful coronary stenting, Can J Cardiol, 26, e54, 10.1016/S0828-282X(10)70008-8

Stockl, 2010, Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor, Arch Intern Med, 170, 704, 10.1001/archinternmed.2010.34

Ho, 2009, Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome, JAMA, 301, 937, 10.1001/jama.2009.261

Rassen, 2009, Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome, Circulation, 120, 2322, 10.1161/CIRCULATIONAHA.109.873497

Cuisset, 2009, Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study, J Am Coll Cardiol, 54, 1149, 10.1016/j.jacc.2009.05.050

Neubauer, 2010, Pantoprazole does not influence the antiplatelet effect of clopidogrel a whole blood aggregometry study after coronary stenting, J Cardiovasc Pharmacol, 56, 91, 10.1097/FJC.0b013e3181e19739

Siller-Matula, 2009, Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel, Am Heart J, 157, e1

Kenngott, 2010, Clopidogrel and proton pump inhibitor (PPI) interaction: separate intake and a non-omeprazole PPI the solution?, Eur J Med Res, 15, 220, 10.1186/2047-783X-15-5-220

Juurlink, 2009, Proton pump inhibitors and clopidogrel: putting the interaction in perspective, Circulation, 120, 2310, 10.1161/CIRCULATIONAHA.109.907295

Thông tin
Thông tin xuất bản

Revista Colombiana de Cardiología

Tập 19

25-32

Thông tin tác giả